Pharmathen Global BV

About Pharmathen Global BV

We are one of the leading complex drug delivery and formulation developers, using our key in-house technologies to support improved patient compliance. We service a broad partner network of over 250 customers in over 90 countries throughout Europe, North America, South America,  Middle East, Asia, Australasia and Southern Africa.
Our portfolio consists of over 100 products, and today we are working on one of the most extensive and advanced pipelines in Long Acting Injectables, Sustained Release formulations and Preservative Free Ophthalmics, produced in our in-house US-FDA and EU-approved facilities.
In Long Acting Injectables all 3 key technology platforms (Microspheres, Nanosuspensions and Nano-Gels) are fully validated to commercial scale across multiple products in multiple countries. These platforms now support the enrichment of our pipeline with our selection of Long-Acting Therapeutic Technologies (LATTs) which target enhanced patient compliance for existing drug delivery metho...

Certifications
  • NL
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from Pharmathen Global BV (5)

  • Sevelamer Carbonate Chewable

    Product Sevelamer Carbonate Chewable

    Pharmaceutical form: fast disintegrating chewable tablets. Therapeutic category: Control of serum phosphorous in patients with chronic kidney disease.
    Strengths: 800mg.
    Contact us for more information.
    Products which are subject to patent protection are currently not offered or...
  • Bimatoprost

    Product Bimatoprost

    Pharmaceutical form: eye drops solution. Therapeutic indication: reduction of elevated intraocular pressure in open angle glaucoma ocular hypertension.
    Strengths: 0.1mg/ml, 0.3mg/ml
    Contact us for more information.
    Products which are subject to patent protection are cur...
  • Aripiprazole LAI

    Product Aripiprazole LAI

    Pharmaceutical form: Long acting injectable. Therapeutic category: Treatment of schizophrenia.
    Strengths: 300mg/vial & 400mg/vial ,300mg/syringe & 400mg/syringe.
    Contact us for more information.
    Products which are subject to patent protection are currently not offered or mad...
  • Alendronate + Cholecalciferol

    Product Alendronate + Cholecalciferol

    Pharmaceutical form: Tablets Therapeutic category: Postmenopausal osteoporosis.
    Strengths: 70mg/2800IU & 70mg/5600IU
    Contact us for more information.
    Products which are subject to patent protection are currently not offered or made available in Germany or in countries wher...
  • Aprepitant

    Product Aprepitant

    Pharmaceutical form: Hard Capsules. Therapeutic category: Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults.
    Strengths: 40mg, 80mg, 125mg, 165mg (Not available in the US market).
    Contact us for more information.  
    Produ...

Pharmathen Global BV Resources (2)